Nonmedical cannabis legalization policy in Canada: Has commercialization been a pivotal mistake for public health? DOI Creative Commons
Benedikt Fischer, Wayne Hall, Didier Jutras‐Aswad

et al.

World Medical & Health Policy, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 25, 2024

Abstract Canada implemented the legalization of nonmedical cannabis use and supply in 2018. Initial blueprints for policy framework emphasized public health protection as a priority principle objective, including related design parameters regulatory restrictions (e.g., strict access distribution control, advertisement/promotion ban, etc.) also informed by adverse experiences from alcohol/tobacco control. Conversely, Canada's present ecology is characterized increasingly far‐reaching commercialization; this includes an extensive for‐profit production retail industry producing large sales volumes that centrally include high‐risk products, with many health‐oriented provisions hollowed out or circumvented practice. While key cannabis‐related problem indicators have increased through legalization, mounting evidence suggests these outcome dynamics, to crucial extent, been accelerated commercialization aspects legalization. Meanwhile, since has pushed further rollbacks benefits competitiveness. Using Canadian case study, we focus on possible pitfalls effects dynamics Also commercialization‐related developments outcomes are hard reverse, urge jurisdictions planning reforms carefully take consider when assembling their frameworks.

Language: Английский

Germany's cannabis act: a catalyst for European drug policy reform? DOI Creative Commons
Jakob Manthey,

Jürgen Rehm,

Uwe Verthein

et al.

The Lancet Regional Health - Europe, Journal Year: 2024, Volume and Issue: 42, P. 100929 - 100929

Published: May 14, 2024

With the enforcement of Cannabis Act on 1 April 2024, Germany has adopted one most liberal legal approaches to cannabis continent. The German model prioritises a non-profit approach and precludes market mechanisms. We believe these are main drivers for increasing use related health problems, based observations following legalisation in Canada many states U.S. Although legalising possession cultivation may not immediately eliminate illegal market, it is expected serve public goals. Despite overall positive evaluation Germany, there three potential areas concern: misuse medical system, normalization use, influence industry. herald beginning new generation European policies, but concerted efforts will be required ensure that policy reforms rather than undermine

Language: Английский

Citations

6
Should cannabis self-cultivation be part of a public health‒oriented legalization policy framework? DOI
Benedikt Fischer, Tessa Robinson

Can J Public Health, Journal Year: 2024, Volume and Issue: 115(5), P. 784 - 788

Published: July 24, 2024

Language: Английский

Citations

0
Managing the Unavoidable Conflicts Between Protecting Public Health, Reducing the Illicit Cannabis Market, and Raising Tax Revenue When Legalizing Adult Cannabis Use DOI
Wayne Hall, Benedikt Fischer

SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice, Journal Year: 2024, Volume and Issue: 70(4), P. 193 - 195

Published: Aug. 1, 2024

Language: Английский

Citations

0
Nonmedical cannabis legalization policy in Canada: Has commercialization been a pivotal mistake for public health? DOI Creative Commons
Benedikt Fischer, Wayne Hall, Didier Jutras‐Aswad

et al.

World Medical & Health Policy, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 25, 2024

Abstract Canada implemented the legalization of nonmedical cannabis use and supply in 2018. Initial blueprints for policy framework emphasized public health protection as a priority principle objective, including related design parameters regulatory restrictions (e.g., strict access distribution control, advertisement/promotion ban, etc.) also informed by adverse experiences from alcohol/tobacco control. Conversely, Canada's present ecology is characterized increasingly far‐reaching commercialization; this includes an extensive for‐profit production retail industry producing large sales volumes that centrally include high‐risk products, with many health‐oriented provisions hollowed out or circumvented practice. While key cannabis‐related problem indicators have increased through legalization, mounting evidence suggests these outcome dynamics, to crucial extent, been accelerated commercialization aspects legalization. Meanwhile, since has pushed further rollbacks benefits competitiveness. Using Canadian case study, we focus on possible pitfalls effects dynamics Also commercialization‐related developments outcomes are hard reverse, urge jurisdictions planning reforms carefully take consider when assembling their frameworks.

Language: Английский

Citations

0